Načítá se...
Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade
The success of immune checkpoint receptor blockade has brought exciting promises for the treatment of head and neck squamous cell carcinoma (HNSCC). While patients who respond to checkpoint inhibitors tend to develop a durable response, <15% of patients with HNSCC respond to immune checkpoint inh...
Uloženo v:
| Vydáno v: | J Dent Res |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6704427/ https://ncbi.nlm.nih.gov/pubmed/31340724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034519864112 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|